Janssen Biotech, Inc. v. Celltrion Healthcare Co. Ltd. at al. (17-cv-11008).

Judge Wolf denied defendants’ motion to dismiss Janssen’s counterclaim of violation of 35 U.S.C. § 271(f), finding that the counterclaim pled all of the necessary elements of such a claim.  Janssen did not bring this claim in its original complaint, instead bringing it in its answer to the defendants’ counterclaim seeking a declaration of non-infringement and invalidity.  Judge Wolf found the counterclaim to be of right to Janssen as a compulsory counterclaim, as opposed to an amended pleading that would require leave of court.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s